
CONMED Corporation
Healthcare · USD
Price
$34.08
Cap
$1.1B
Earnings
4/4 beat
30d Trend
-2%
Near 52-week lows — potential value or falling knife
Target range: $39 – $52 (consensus: $44.2)
Consensus: Hold
Earnings history
Q4 2025
BEAT
1.43 vs 1.32
Q3 2025
BEAT
1.08 vs 1.05
Q2 2025
BEAT
1.15 vs 1.13
Q1 2025
BEAT
0.95 vs 0.81
Key macro factors
Global Growth Slowdown & Geopolitical Uncertainty: The ongoing Middle East conflict and the IMF's anticipated downgrade of global growth forecasts could lead to reduced demand for elective procedures and constrained healthcare spending. Higher oil prices also increase operational and shipping costs, impacting profitability. [cite: 34 (previous searches)]
Inflationary Pressures & Supply Chain Disruptions: Elevated oil prices, influenced by geopolitical tensions, could increase CONMED's operational costs for manufacturing, transportation, and raw materials, thereby impacting profit margins. [cite: 34 (previous searches)]
Hospital Capital Spending & Elective Procedure Volumes: The broader economic climate directly influences hospital budgets for capital expenditures and patient willingness to undergo elective surgeries, which are key drivers for medical device sales. The US jobs report, while positive, is set against global uncertainties that may temper confidence in large-scale capital investments within healthcare.
CONMED Corp. is a medical technology company, which engages in providing devices and equipment for surgical procedures.
QUANT SCORE
Want full analysis on every stock?
Brain47 provides AI-powered research across 72,000+ instruments. Stocks, ETFs, REITs and more.
Join Brain47 — FreeGenerated by Brain47 AI. Educational research only. Not financial advice. Brain47 is not authorised by the FCA to provide investment advice.
